Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 2
2007 1
2009 1
2010 2
2011 1
2012 2
2013 1
2015 2
2016 1
2017 2
2018 2
2019 1
2020 1
2021 3
2022 3
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.
Wakelee H, Liberman M, Kato T, Tsuboi M, Lee SH, Gao S, Chen KN, Dooms C, Majem M, Eigendorff E, Martinengo GL, Bylicki O, Rodríguez-Abreu D, Chaft JE, Novello S, Yang J, Keller SM, Samkari A, Spicer JD; KEYNOTE-671 Investigators. Wakelee H, et al. N Engl J Med. 2023 Aug 10;389(6):491-503. doi: 10.1056/NEJMoa2302983. Epub 2023 Jun 3. N Engl J Med. 2023. PMID: 37272513 Clinical Trial.
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
Mok TSK, Wu YL, Kudaba I, Kowalski DM, Cho BC, Turna HZ, Castro G Jr, Srimuninnimit V, Laktionov KK, Bondarenko I, Kubota K, Lubiniecki GM, Zhang J, Kush D, Lopes G; KEYNOTE-042 Investigators. Mok TSK, et al. Lancet. 2019 May 4;393(10183):1819-1830. doi: 10.1016/S0140-6736(18)32409-7. Epub 2019 Apr 4. Lancet. 2019. PMID: 30955977 Clinical Trial.
Sarcoidosis--moving to the new standard of diagnosis?
Miliauskas S, Zemaitis M, Sakalauskas R. Miliauskas S, et al. Among authors: zemaitis m. Medicina (Kaunas). 2010;46(7):443-6. Medicina (Kaunas). 2010. PMID: 20966615 Free article. Review.
Multidrug-resistant tuberculosis in Lithuania - Still a long way ahead.
Musteikienė G, Miliauskas S, Sakalauskas R, Vitkauskienė A, Žemaitis M. Musteikienė G, et al. Among authors: zemaitis m. Medicina (Kaunas). 2016;52(2):69-78. doi: 10.1016/j.medici.2016.02.002. Epub 2016 Mar 3. Medicina (Kaunas). 2016. PMID: 27170479 Free article. Review.
Post COVID-19 Organizing Pneumonia: The Right Time to Interfere.
Bieksiene K, Zaveckiene J, Malakauskas K, Vaguliene N, Zemaitis M, Miliauskas S. Bieksiene K, et al. Among authors: zemaitis m. Medicina (Kaunas). 2021 Mar 18;57(3):283. doi: 10.3390/medicina57030283. Medicina (Kaunas). 2021. PMID: 33803690 Free PMC article.
Is analysis of inflammatory biomarkers and lymphocyte subpopulations useful in prediction of tuberculosis treatment outcomes?
Musteikienė G, Miliauskas S, Zaveckienė J, Urbonienė D, Vitkauskienė A, Žemaitis M, Naudžiūnas A. Musteikienė G, et al. Among authors: zemaitis m. J Clin Tuberc Other Mycobact Dis. 2021 Sep 8;25:100275. doi: 10.1016/j.jctube.2021.100275. eCollection 2021 Dec. J Clin Tuberc Other Mycobact Dis. 2021. PMID: 34541339 Free PMC article.
Care of patients with non-small-cell lung cancer stage III - the Central European real-world experience.
Zemanova M, Pirker R, Petruzelka L, Zbozínkova Z, Jovanovic D, Rajer M, Bogos K, Purkalne G, Ceriman V, Chaudhary S, Richter I, Kufa J, Jakubikova L, Zemaitis M, Cernovska M, Koubkova L, Vilasova Z, Dieckmann K, Farkas A, Spasic J, Fröhlich K, Tiefenbacher A, Hollosi V, Kultan J, Kolarová I, Votruba J. Zemanova M, et al. Among authors: zemaitis m. Radiol Oncol. 2020 May 28;54(2):209-220. doi: 10.2478/raon-2020-0026. Radiol Oncol. 2020. PMID: 32463394 Free PMC article.
30 results